Hatice Mutlu Albayrak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hatice Mutlu Albayrak has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Ece Eker
Department of Pediatric Genetics Ankara University, School of Medicine Ankara Turkiye
4 shared publications - Arzu Ay
Department of Pediatric Genetics Ankara University, School of Medicine Ankara Turkiye
3 shared publications Emre Kırat
3 shared publications- Peren Perk
Başakşehir Çam ve Sakura City Hospital, Türkiye
3 shared publications - Aslıhan Sanrı
Department of Pediatric Genetics, Samsun Training and Research Hospital, Samsun, Turkey
2 shared publications - Fatma Tuba Eminoğlu
Department of Pediatric Metabolism, Ankara University Faculty of Medicine, Ankara, Türkiye
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 5 (48) , 505
Limited Public Health Utility of LCT Genotyping for Lactose Intolerance Screening in Adolescents: A Cross-Sectional Study from Türkiye
Objective: Lactose intolerance (LI) is a common cause of gastrointestinal complaints in adolescents and young adults, often leading to unnecessary dietary restrictions and reduced calcium intake. Although lactase non-persistence (LNP) is genetically determined, its clinical expression varies considerably. Genetic variants associated with lactase persistence/non-persistence (LCT/MCM6 locus), particularly rs4988235 and rs3754686, are frequently used in genetic testing; however, their clinical utility remains uncertain, especially in populations with a high prevalence of LNP, such as Türkiye. Materials and Methods: In this cross-sectional study, 209 individuals aged 12–25 years were evaluated. Lactose-related symptoms were assessed using a validated questionnaire (a score ≥7 defined symptomatic individuals). Consumption of raw milk and fermented dairy products was recorded using a standardized frequency scale. Genotyping of rs4988235 and rs3754686 was performed using TaqMan real-time PCR. Associations between genotype, symptom status, age at symptom onset, and dietary patterns were statistically analyzed. Results: Among the participants, 116 (55.5%) were symptomatic and 93 (44.5%) were asymptomatic. Symptomatic individuals were significantly older (p<0.001). The genotype distributions of rs4988235 and rs3754686 did not differ between symptomatic and asymptomatic individuals and were not associated with age at symptom onset. Dairy consumption patterns were not associated with symptom severity, although fermented dairy consumption was slightly higher among symptomatic individuals (p=0.046). Conclusion: Common LCT/MCM6 variants did not predict clinical LI in this adolescent and young adult population. Therefore, routine genetic testing appears unlikely to provide limited additional value in supporting the diagnosis of lactose intolerance, particularly in populations with a high prevalence of LNP. Symptom-based assessment and functional testing should remain central to diagnosis and management, and, supporting appropriate nutritional guidance and avoiding unnecessary dietary restriction.
- 8 October 2026
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 5 (48) , 505
Open AccessLimited Public Health Utility of LCT Genotyping for Lactose Intolerance Screening in Adolescents: A Cross-Sectional Study from Türkiye
Objective: Lactose intolerance (LI) is a common cause of gastrointestinal complaints in adolescents and young adults, often leading to unnecessary dietary restrictions and reduced calcium intake. Although lactase non-persistence (LNP) is genetically determined, its clinical expression varies considerably. Genetic variants associated with lactase persistence/non-persistence (LCT/MCM6 locus), particularly rs4988235 and rs3754686, are frequently used in genetic testing; however, their clinical utility remains uncertain, especially in populations with a high prevalence of LNP, such as Türkiye. Materials and Methods: In this cross-sectional study, 209 individuals aged 12–25 years were evaluated. Lactose-related symptoms were assessed using a validated questionnaire (a score ≥7 defined symptomatic individuals). Consumption of raw milk and fermented dairy products was recorded using a standardized frequency scale. Genotyping of rs4988235 and rs3754686 was performed using TaqMan real-time PCR. Associations between genotype, symptom status, age at symptom onset, and dietary patterns were statistically analyzed. Results: Among the participants, 116 (55.5%) were symptomatic and 93 (44.5%) were asymptomatic. Symptomatic individuals were significantly older (p<0.001). The genotype distributions of rs4988235 and rs3754686 did not differ between symptomatic and asymptomatic individuals and were not associated with age at symptom onset. Dairy consumption patterns were not associated with symptom severity, although fermented dairy consumption was slightly higher among symptomatic individuals (p=0.046). Conclusion: Common LCT/MCM6 variants did not predict clinical LI in this adolescent and young adult population. Therefore, routine genetic testing appears unlikely to provide limited additional value in supporting the diagnosis of lactose intolerance, particularly in populations with a high prevalence of LNP. Symptom-based assessment and functional testing should remain central to diagnosis and management, and, supporting appropriate nutritional guidance and avoiding unnecessary dietary restriction.
- 21 August 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (8)
A Tiered Genetic Diagnostic Approach in Newborns With Major Congenital Anomalies: Experience From a Tertiary NICU
Background: Major congenital anomalies (MCAs) are a leading cause of neonatal morbidity and mortality and frequently reflect underlying chromosomal, copy number, or single‐gene defects. In neonates with multiple MCAs, early molecular diagnosis is critical but remains challenging due to phenotypic heterogeneity, overlapping developmental pathways, and limitations in selecting the most appropriate genetic test. Methods: This prospective study included 146 neonates with congenital anomalies who were referred for genetic consultation from a tertiary neonatal intensive care unit between April 2022 and May 2025. A major congenital anomaly was defined as a structural abnormality present at birth with significant medical, functional, or cosmetic consequences, while multiple congenital anomalies were defined as two or more major anomalies involving different organ systems. Clinical features were systematically annotated using Human Phenotype Ontology terms and classified according to organ system and embryological origin. A tiered diagnostic strategy was applied, including conventional cytogenetic analysis, chromosomal microarray analysis (CMA), whole‐exome sequencing (WES), and rapid‐WES (rWES) in selected critically ill neonates. Results: Cardiovascular anomalies were the most frequent (45.9%), and 88 of 146 neonates (60.3%) had two or more MCAs. Cytogenetic testing identified numerical chromosomal abnormalities in eight neonates. CMA detected pathogenic or likely pathogenic copy number variants in 6 of 65 tested cases (9.1%). In CMA‐negative patients, WES achieved a diagnostic yield of 41.4%, identifying variants in genes involved in multisystem developmental pathways. Rapid WES established definitive molecular diagnoses in two of three critically ill neonates within 72 h, directly influencing clinical management. Embryological analysis revealed recurrent co‐occurrence patterns, particularly cardiovascular–craniofacial and cardiovascular–genitourinary associations. Conclusion: A structured, tiered genomic approach enhances diagnostic yield in neonates with congenital anomalies. Integration of cytogenetics, CMA, and CNV‐aware exome sequencing provides a pragmatic and clinically actionable framework for molecular diagnosis in NICU settings and supports developmentally informed interpretation of complex phenotypes.
- 21 August 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (8)
A Tiered Genetic Diagnostic Approach in Newborns With Major Congenital Anomalies: Experience From a Tertiary NICU
Background: Major congenital anomalies (MCAs) are a leading cause of neonatal morbidity and mortality and frequently reflect underlying chromosomal, copy number, or single‐gene defects. In neonates with multiple MCAs, early molecular diagnosis is critical but remains challenging due to phenotypic heterogeneity, overlapping developmental pathways, and limitations in selecting the most appropriate genetic test. Methods: This prospective study included 146 neonates with congenital anomalies who were referred for genetic consultation from a tertiary neonatal intensive care unit between April 2022 and May 2025. A major congenital anomaly was defined as a structural abnormality present at birth with significant medical, functional, or cosmetic consequences, while multiple congenital anomalies were defined as two or more major anomalies involving different organ systems. Clinical features were systematically annotated using Human Phenotype Ontology terms and classified according to organ system and embryological origin. A tiered diagnostic strategy was applied, including conventional cytogenetic analysis, chromosomal microarray analysis (CMA), whole‐exome sequencing (WES), and rapid‐WES (rWES) in selected critically ill neonates. Results: Cardiovascular anomalies were the most frequent (45.9%), and 88 of 146 neonates (60.3%) had two or more MCAs. Cytogenetic testing identified numerical chromosomal abnormalities in eight neonates. CMA detected pathogenic or likely pathogenic copy number variants in 6 of 65 tested cases (9.1%). In CMA‐negative patients, WES achieved a diagnostic yield of 41.4%, identifying variants in genes involved in multisystem developmental pathways. Rapid WES established definitive molecular diagnoses in two of three critically ill neonates within 72 h, directly influencing clinical management. Embryological analysis revealed recurrent co‐occurrence patterns, particularly cardiovascular–craniofacial and cardiovascular–genitourinary associations. Conclusion: A structured, tiered genomic approach enhances diagnostic yield in neonates with congenital anomalies. Integration of cytogenetics, CMA, and CNV‐aware exome sequencing provides a pragmatic and clinically actionable framework for molecular diagnosis in NICU settings and supports developmentally informed interpretation of complex phenotypes.
- 19 August 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (5) , 558-573
Sotos and Malan Syndromes in Childhood: Molecular and Clinical Findings From a Nationwide Cohort of 48 Patients
Sotos syndrome is an overgrowth disorder caused by heterozygous NSD1 variants, partial‐gene deletions, or 5q35 microdeletions. Malan syndrome, a phenotypically overlapping condition, results from haploinsufficiency of the NFIX gene due to either heterozygous chromosomal microdeletions involving the 19p13.2 region or heterozygous loss‐of‐function variants. This multicenter study aimed to characterize the clinical and molecular features of individuals with Sotos and Malan syndromes in Türkiye. We retrospectively analyzed clinical and molecular data from 48 individuals with genetically confirmed Sotos or Malan syndrome across 14 centers. Molecular analyses included whole‐exome sequencing, clinical exome sequencing, targeted gene panels, multiplex ligation–dependent probe amplification, and chromosomal microarray analysis. Forty‐two individuals were diagnosed with Sotos syndrome and six with Malan syndrome. All exhibited characteristic facial features, and 97.9% had developmental delay or intellectual disability. We identified a total of 38 NSD1 variants, of which 35 were classified as pathogenic or likely pathogenic and three as variants of uncertain significance; notably, 23 of these variants were novel. Three patients carried 5q35 microdeletions, and one had an intragenic deletion involving exons 10–11. Four distinct NFIX variants (two novel) were detected in five patients, and one carried a 19p13.13 deletion encompassing the entire gene. This nationwide study expands the genotype–phenotype spectrum of Sotos and Malan syndromes in Türkiye and supports improved diagnostic and clinical management strategies.
- 19 August 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (5) , 558-573
Sotos and Malan Syndromes in Childhood: Molecular and Clinical Findings From a Nationwide Cohort of 48 Patients
Sotos syndrome is an overgrowth disorder caused by heterozygous NSD1 variants, partial‐gene deletions, or 5q35 microdeletions. Malan syndrome, a phenotypically overlapping condition, results from haploinsufficiency of the NFIX gene due to either heterozygous chromosomal microdeletions involving the 19p13.2 region or heterozygous loss‐of‐function variants. This multicenter study aimed to characterize the clinical and molecular features of individuals with Sotos and Malan syndromes in Türkiye. We retrospectively analyzed clinical and molecular data from 48 individuals with genetically confirmed Sotos or Malan syndrome across 14 centers. Molecular analyses included whole‐exome sequencing, clinical exome sequencing, targeted gene panels, multiplex ligation–dependent probe amplification, and chromosomal microarray analysis. Forty‐two individuals were diagnosed with Sotos syndrome and six with Malan syndrome. All exhibited characteristic facial features, and 97.9% had developmental delay or intellectual disability. We identified a total of 38 NSD1 variants, of which 35 were classified as pathogenic or likely pathogenic and three as variants of uncertain significance; notably, 23 of these variants were novel. Three patients carried 5q35 microdeletions, and one had an intragenic deletion involving exons 10–11. Four distinct NFIX variants (two novel) were detected in five patients, and one carried a 19p13.13 deletion encompassing the entire gene. This nationwide study expands the genotype–phenotype spectrum of Sotos and Malan syndromes in Türkiye and supports improved diagnostic and clinical management strategies.
- Open Access
- 7 May 2026
- Published by BMJ in BMJ Connections Clinical Genetics and Genomics
- Vol. 3 (1) , e000070
SOX17 as a candidate gene for ovarian dysgenesis: functional characterisation of a novel homozygous variant
Background: Ovarian dysgenesis is a genetically heterogeneous disorder, and recent studies have implicated novel candidate genes that continue to emerge beyond the classical regulators of gonadal development. SOX17 is a transcription factor essential for human primordial germ cell specification and early germline development. While heterozygous variants have been associated with congenital anomalies of the kidney and urinary tract, their potential role in ovarian development remains unclear. Methods: We investigated a consanguineous family in which two sisters presented with clinical features consistent with 46, XX ovarian dysgenesis. Whole-exome sequencing was performed under an autosomal recessive inheritance model. Variant interpretation followed American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines. Pathogenicity was further explored using conservation analysis, in silico prediction tools, homology-based structural modelling, protein stability analysis and protein–DNA docking simulations. Results: A novel homozygous SOX17 missense variant (c.366G>C; p.Glu122Asp) was identified in both affected siblings and segregated with disease within the family. The variant is extremely rare in population databases and affects a highly conserved residue within the high-mobility group DNA-binding domain. Multiple computational tools predicted a deleterious effect. Structural modelling and stability analyses suggested localised destabilisation and increased flexibility, while docking simulations indicated reduced predicted DNA-binding affinity compared with the wild-type protein. Conclusion: Our findings support SOX17 as a plausible candidate gene for autosomal recessive ovarian dysgenesis. Although functional validation studies are required to establish causality, the combined segregation data, conservation analysis and in silico modelling suggest that the identified variant may impair SOX17 DNA-binding capacity and contribute to abnormal ovarian development.
- 7 May 2026
- Published by BMJ in BMJ Connections Clinical Genetics and Genomics
- Vol. 3 (1) , e000070
Open AccessSOX17 as a candidate gene for ovarian dysgenesis: functional characterisation of a novel homozygous variant
Background: Ovarian dysgenesis is a genetically heterogeneous disorder, and recent studies have implicated novel candidate genes that continue to emerge beyond the classical regulators of gonadal development. SOX17 is a transcription factor essential for human primordial germ cell specification and early germline development. While heterozygous variants have been associated with congenital anomalies of the kidney and urinary tract, their potential role in ovarian development remains unclear. Methods: We investigated a consanguineous family in which two sisters presented with clinical features consistent with 46, XX ovarian dysgenesis. Whole-exome sequencing was performed under an autosomal recessive inheritance model. Variant interpretation followed American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines. Pathogenicity was further explored using conservation analysis, in silico prediction tools, homology-based structural modelling, protein stability analysis and protein–DNA docking simulations. Results: A novel homozygous SOX17 missense variant (c.366G>C; p.Glu122Asp) was identified in both affected siblings and segregated with disease within the family. The variant is extremely rare in population databases and affects a highly conserved residue within the high-mobility group DNA-binding domain. Multiple computational tools predicted a deleterious effect. Structural modelling and stability analyses suggested localised destabilisation and increased flexibility, while docking simulations indicated reduced predicted DNA-binding affinity compared with the wild-type protein. Conclusion: Our findings support SOX17 as a plausible candidate gene for autosomal recessive ovarian dysgenesis. Although functional validation studies are required to establish causality, the combined segregation data, conservation analysis and in silico modelling suggest that the identified variant may impair SOX17 DNA-binding capacity and contribute to abnormal ovarian development.
- 24 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (4) , 312-319
Isolated and Syndromic Talipes Equinovarus in Children: Differences in Clinical Presentation and Quality of Life
Objective: Talipes equinovarus (TEV) is a congenital foot deformity that can present either in an isolated form or as part of a syndromic condition. In syndromic TEV, dysmorphic features, systemic anomalies, and developmental delay are more frequently observed. This study aims to evaluate the differences in clinical characteristics, dysmorphic findings, and quality of life between isolated and syndromic forms of TEV in children. Materials and Methods: Ninety TEV patients (37 syndromic, 53 isolated) diagnosed between 2010 and 2022 were included. Demographic and clinical data were retrospectively reviewed. Additional anomalies and dysmorphic features were prospectively assessed. Quality of life in children aged ≥2 years and their caregivers was evaluated using the Pediatric Quality of Life Inventory (PedsQL). Results: Consanguinity, low birth weight and developmental delay were significantly more frequent in the syndromic TEV group (P=.005, P=.014, P=.014), with central nervous system anomalies being the most common. The PedsQL scores were highest in controls, followed by isolated TEV, and lowest in syndromic TEV (P < .001, P < .001). Quality of life was negatively correlated with dysmorphic feature count (P < .001). Conclusion: Quality of life in children with syndromic TEV is significantly affected by physical and psychosocial factors. Syndromic TEV is associated with a more complex clinical course and lower quality of life compared to the isolated form. Early diagnosis, clinical genetic evaluation, multidisciplinary management, and psychosocial support may enhance treatment success and quality of life.
- 24 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (4) , 312-319
Isolated and Syndromic Talipes Equinovarus in Children: Differences in Clinical Presentation and Quality of Life
Objective: Talipes equinovarus (TEV) is a congenital foot deformity that can present either in an isolated form or as part of a syndromic condition. In syndromic TEV, dysmorphic features, systemic anomalies, and developmental delay are more frequently observed. This study aims to evaluate the differences in clinical characteristics, dysmorphic findings, and quality of life between isolated and syndromic forms of TEV in children. Materials and Methods: Ninety TEV patients (37 syndromic, 53 isolated) diagnosed between 2010 and 2022 were included. Demographic and clinical data were retrospectively reviewed. Additional anomalies and dysmorphic features were prospectively assessed. Quality of life in children aged ≥2 years and their caregivers was evaluated using the Pediatric Quality of Life Inventory (PedsQL). Results: Consanguinity, low birth weight and developmental delay were significantly more frequent in the syndromic TEV group (P=.005, P=.014, P=.014), with central nervous system anomalies being the most common. The PedsQL scores were highest in controls, followed by isolated TEV, and lowest in syndromic TEV (P < .001, P < .001). Quality of life was negatively correlated with dysmorphic feature count (P < .001). Conclusion: Quality of life in children with syndromic TEV is significantly affected by physical and psychosocial factors. Syndromic TEV is associated with a more complex clinical course and lower quality of life compared to the isolated form. Early diagnosis, clinical genetic evaluation, multidisciplinary management, and psychosocial support may enhance treatment success and quality of life.
- 24 December 2025
- Published by Springer Nature in Acta Neurologica Belgica
ANO3-related tremulous dystonia: case report
A 21-year-old woman presented with a severe tremor and involuntary spasms in her hands. Her tremor started at the age of seven, and while it was initially mild and only in bilateral upper extremities, its severity increased over time. There is no consanguinity between her parents, and her early developmental milestones are consistent with her age. Her father had involuntary movements with similar semiology. The neurological examination revealed a mild intellectual disability, head titubation, postural and action tremors, and dystonia affecting the bilateral distal upper extremities. Brain magnetic resonance imaging and investigations for neurometabolic diseases were normal. Exome sequencing analysis revealed a heterozygous likely pathogenic variant of ANO3 gene ([NM_031418.4]:c.1943A>G p.[Asn648Ser]), and she was diagnosed with ANO3-related dystonia (DYT-ANO3). She was started on trihexyphenidyl, and at the follow-up, partial improvement in her involuntary movements was observed.DYT-ANO3 caused by pathogenic variants of ANO3 gene were first described in families affected by adult-onset tremulous craniocervical dystonia, and since then, the phenotypic spectrum has expanded significantly. The onset of clinical features may vary from the first months of life to adulthood, and cases may present with a wide range of clinical spectrum, from focal/segmental to generalized dystonia, and from isolated to tremulous or jerky dystonia. Cases with the same genotype may present with movement disorders of different characteristics, suggesting that there is no definitive genotype-phenotype correlation in DYT-ANO3 cases. Additionally, cases with nondystonic features, such as nondystonic tremor, myoclonus and/or neurodevelopmental delay have also been reported.
- 24 December 2025
- Published by Springer Nature in Acta Neurologica Belgica
ANO3-related tremulous dystonia: case report
A 21-year-old woman presented with a severe tremor and involuntary spasms in her hands. Her tremor started at the age of seven, and while it was initially mild and only in bilateral upper extremities, its severity increased over time. There is no consanguinity between her parents, and her early developmental milestones are consistent with her age. Her father had involuntary movements with similar semiology. The neurological examination revealed a mild intellectual disability, head titubation, postural and action tremors, and dystonia affecting the bilateral distal upper extremities. Brain magnetic resonance imaging and investigations for neurometabolic diseases were normal. Exome sequencing analysis revealed a heterozygous likely pathogenic variant of ANO3 gene ([NM_031418.4]:c.1943A>G p.[Asn648Ser]), and she was diagnosed with ANO3-related dystonia (DYT-ANO3). She was started on trihexyphenidyl, and at the follow-up, partial improvement in her involuntary movements was observed.DYT-ANO3 caused by pathogenic variants of ANO3 gene were first described in families affected by adult-onset tremulous craniocervical dystonia, and since then, the phenotypic spectrum has expanded significantly. The onset of clinical features may vary from the first months of life to adulthood, and cases may present with a wide range of clinical spectrum, from focal/segmental to generalized dystonia, and from isolated to tremulous or jerky dystonia. Cases with the same genotype may present with movement disorders of different characteristics, suggesting that there is no definitive genotype-phenotype correlation in DYT-ANO3 cases. Additionally, cases with nondystonic features, such as nondystonic tremor, myoclonus and/or neurodevelopmental delay have also been reported.
- 26 May 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Wolcott–Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure – a case report
Objectives: Wolcott–Rallison syndrome (WRS) is an autosomal recessive multisystemic genetic disorder caused by homozygous mutation in the eukaryotic translation initiation factor 2 alpha kinase 3 gene. It typically presents with neonatal onset insulin-dependent diabetes. Here, we report a 14-year-old male patient with WRS who presented with late-onset diabetes mellitus. Case presentation: A 14-year-old male patient presented with acute liver failure secondary to acute gastroenteritis. On physical examination, signs of chronic malnutrition and muscle atrophy in the extremities were evident, accompanied by a waddling gait. Infectious, autoimmune, and metabolic diseases were excluded. Liver tests improved within 3 weeks with supportive treatment. Direct radiographs were consistent with multiple epiphyseal dysplasia. High blood glucose levels were observed at follow-up in the intensive care unit. At the 4-month follow-up, HbA1c increased to 55 mmol/mol (7.2 %) and basal insulin treatment was started at a dose of 0.4U/kg/day. Glycemic control was achieved after 6 months. Conclusions: Diabetes typically manifests within the first 6 months of life, with a median age of 2.5 months, and has been observed in all patients with WRS reported in the literature. Our case is an interesting WRS patient whose diabetes started at the age of 14 years with a novel mutation.
- 26 May 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
Wolcott–Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure – a case report
Objectives: Wolcott–Rallison syndrome (WRS) is an autosomal recessive multisystemic genetic disorder caused by homozygous mutation in the eukaryotic translation initiation factor 2 alpha kinase 3 gene. It typically presents with neonatal onset insulin-dependent diabetes. Here, we report a 14-year-old male patient with WRS who presented with late-onset diabetes mellitus. Case presentation: A 14-year-old male patient presented with acute liver failure secondary to acute gastroenteritis. On physical examination, signs of chronic malnutrition and muscle atrophy in the extremities were evident, accompanied by a waddling gait. Infectious, autoimmune, and metabolic diseases were excluded. Liver tests improved within 3 weeks with supportive treatment. Direct radiographs were consistent with multiple epiphyseal dysplasia. High blood glucose levels were observed at follow-up in the intensive care unit. At the 4-month follow-up, HbA1c increased to 55 mmol/mol (7.2 %) and basal insulin treatment was started at a dose of 0.4U/kg/day. Glycemic control was achieved after 6 months. Conclusions: Diabetes typically manifests within the first 6 months of life, with a median age of 2.5 months, and has been observed in all patients with WRS reported in the literature. Our case is an interesting WRS patient whose diabetes started at the age of 14 years with a novel mutation.
- 8 February 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (3) , 605-616
Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study
- 8 February 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (3) , 605-616
Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (6) , 321-323
Sudden Cardiac Arrest in an Adolescent with X-Linked Ichthyosis
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (6) , 321-323
Open AccessSudden Cardiac Arrest in an Adolescent with X-Linked Ichthyosis
- 1 September 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (3) , 182-194
Evaluation of the Neurodevelopmental Status for Urea Cycle Disorders: Based on Clinical Experience
- 1 September 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (3) , 182-194
Evaluation of the Neurodevelopmental Status for Urea Cycle Disorders: Based on Clinical Experience